Monthly information on share capital and company voting rights
(Article 223-16 of General Regulation of the French financial markets authority)Listing market: Euronext GrowthISIN code: FR0010425595 DateTotal number of shares in the capitalTotal number of voting rights 02/29/202471,751,20177,686,895 For further information on Cellectis, please contact: Media contact: Pascalyne Wilson, Director, Communications, +33 (0)7 76 99 14 33,media@cellectis.com Patricia Sosa Navarro, Chief of Staff to the CEO, +33...
Comunicato Precedente
Comunicato Successivo
(Article 223-16 of General Regulation of the French financial markets authority)
Listing market: Euronext Growth
ISIN code: FR0010425595
| Date | Total number of shares in the capital |
Total number of voting rights |
| 02/29/2024 | 71,751,201 | 77,686,895 |
For further information on Cellectis, please contact:
Media contact:
Pascalyne Wilson, Director, Communications, +33 (0)7 76 99 14 33, media@cellectis.com
Patricia Sosa Navarro, Chief of Staff to the CEO, +33 (0)7 76 77 46 93, media@cellectis.com
Investor Relations contacts:
Arthur Stril, Chief Business Officer, +1 (347) 809 5980, investors@cellectis.com
Ashley R. Robinson, LifeSci Advisors, +1 617 430 7577
Attachment
- Voting_Rights_PR_February 2024_EN
Per maggiori informazioni
Sito Web
cellectis.com
Ufficio Stampa
Nasdaq GlobeNewswire (Leggi tutti i comunicati)
2321 Rosecrans Avenue. Suite 2200
90245 El Segundo Stati Uniti
;
